Results for cancer drug: 101

* Palladia approved for canine mast cell tumors * Pfizer to begin selling drug in early 2010 * First cancer treatment specifically designed for dogs (Adds therapy details, no comment on price) NEW YORK, June...

* Palladia approved for canine mast cell tumors * Pfizer to begin selling drug in early 2010 * Says first cancer treatment specifically designed for dogs NEW YORK, June 3 - Pfizer Inc's <PFE.N> efforts...

* BiPar/Sanofi drug boosts survival 60 pct * AstraZeneca's olaparib shrinks tumors in 1/3 of patients * Other types of cancer might be candidates (Recasts first paragraph; adds reaction, application to other cancers, paragraphs 4...

BOSTON, Feb 4 - More is not always better when it comes to mixing cocktails of drugs to fight cancer, Dutch researchers reported on Wednesday. They found that adding the ImClone drug Erbitux to an...

* Withdraws Zactima plus chemo in non-small cell lung cancer * Analysis shows no overall survival benefit * Blow to pipeline, though Phase III tests will continue * Shares down 1.5 percent LONDON, Oct 28...

* In right patients, Iressa is better as first treatment * Study in European patients shows Tarceva benefit (Adds company comments, paragraphs 15-17) CHICAGO, Aug 19 - Diagnostic tests that look for specific genetic or...

* U.S. panel says toxicity risks likely outweigh benefit * Votes 14-1 against FDA approval of Yondelis * Zeltia shares down 6.5 pct, J&J up 1.25 pct (Adds rejection of second J&J application; updates shares)...

* U.S. panel says toxicity risks likely outweigh benefit * Votes 14-1 against FDA approval of Yondelis (Adds meeting details, background, company comment) NEW YORK, July 15 - A Johnson & Johnson and Zeltia SA...

* Chemotherapy cream improves skin appearance * Triggers wound response that builds collagen CHICAGO, June 15 - A cream used to treat the early signs of skin cancer may erase wrinkles and leave behind younger-looking...

* Cut tumour size by 50 percent or more in mid-stage trial * Started late-stage trial in lymphoma * Seen as one of Novartis' most important new drugs * Shares rise 1.1 percent ZURICH, June...